{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:15:16Z","timestamp":1784754916332,"version":"3.55.0"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193844","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T17:38:25Z","timestamp":1521049105000},"page":"e0193844","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4648-8251","authenticated-orcid":true,"given":"Peter Moritz","family":"Becher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Fluschnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan K.","family":"Hennigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Klingel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"AL Bui","year":"2011","journal-title":"Nature reviews Cardiology"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"JJ McMurray","year":"2012","journal-title":"European journal of heart failure"},{"issue":"16","key":"ref3","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"CW Yancy","year":"2013","journal-title":"Circulation"},{"issue":"14","key":"ref4","doi-asserted-by":"crossref","first-page":"E765","DOI":"10.1503\/cmaj.111958","article-title":"Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007","volume":"184","author":"DF Yeung","year":"2012","journal-title":"CMAJ: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/eurjhf\/hft064","article-title":"The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden","volume":"15","author":"R Zarrinkoub","year":"2013","journal-title":"European journal of heart failure"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"MM Redfield","year":"2003","journal-title":"Jama"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/RES.0b013e3182582523","article-title":"Animal models of heart failure: a scientific statement from the American Heart Association","volume":"111","author":"SR Houser","year":"2012","journal-title":"Circulation research"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2538263","DOI":"10.1155\/2016\/2538263","article-title":"Experimental Heart Failure Models and Their Pathophysiological Characterization","volume":"2016","author":"PM Becher","year":"2016","journal-title":"BioMed research international"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurjhf\/hfn043","article-title":"Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology","volume":"11","author":"S Heymans","year":"2009","journal-title":"European journal of heart failure"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"S Akira","year":"2004","journal-title":"Nature reviews Immunology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"181394","DOI":"10.1155\/2012\/181394","article-title":"The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease","volume":"2012","author":"R Spirig","year":"2012","journal-title":"Cardiology research and practice"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e2234","DOI":"10.1038\/cddis.2016.140","article-title":"The emerging role of Toll-like receptor 4 in myocardial inflammation","volume":"7","author":"Y Yang","year":"2016","journal-title":"Cell death & disease"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2174\/1381612053507512","article-title":"Innate immunity and the heart","volume":"11","author":"S Frantz","year":"2005","journal-title":"Current pharmaceutical design"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.2741\/3114","article-title":"Toll-like receptor signaling in the ischemic heart","volume":"13","author":"S Frantz","year":"2008","journal-title":"Frontiers in bioscience: a journal and virtual library"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI6709","article-title":"Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium","volume":"104","author":"S Frantz","year":"1999","journal-title":"The Journal of clinical investigation"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.4049\/jimmunol.1002029","article-title":"TRIF is a critical survival factor in viral cardiomyopathy","volume":"186","author":"A Riad","year":"2011","journal-title":"Journal of immunology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.109.880187","article-title":"Myocardial ischemia\/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody","volume":"121","author":"F Arslan","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"H732","DOI":"10.1152\/ajpheart.00948.2011","article-title":"TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes","volume":"303","author":"B Dong","year":"2012","journal-title":"American journal of physiology Heart and circulatory physiology"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"H184","DOI":"10.1152\/ajpheart.00328.2013","article-title":"Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension","volume":"306","author":"CG McCarthy","year":"2014","journal-title":"American journal of physiology Heart and circulatory physiology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6590609","DOI":"10.1155\/2017\/6590609","article-title":"Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis","volume":"2017","author":"PM Becher","year":"2017","journal-title":"Journal of immunology research"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s000590050009","article-title":"Molecular pathology and structural features of enteroviral replication. Toward understanding the pathogenesis of viral heart disease","volume":"25","author":"K Klingel","year":"2000","journal-title":"Herz"},{"issue":"16","key":"ref22","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1128\/JVI.00047-08","article-title":"Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-\/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis","volume":"82","author":"AO Weinzierl","year":"2008","journal-title":"Journal of virology"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1053-2498(03)00106-2","article-title":"Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices","volume":"23","author":"EJ Birks","year":"2004","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"issue":"2\u20133","key":"ref24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0928-0197(96)00217-6","article-title":"Molecular in situ localization techniques in diagnosis and pathogenicity studies of enteroviral heart disease","volume":"5","author":"K Klingel","year":"1996","journal-title":"Clinical and diagnostic virology"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCHEARTFAILURE.113.000604","article-title":"Interleukin-23 deficiency leads to impaired wound healing and adverse prognosis after myocardial infarction","volume":"7","author":"K Savvatis","year":"2014","journal-title":"Circulation Heart failure"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2337\/db08-0329","article-title":"Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy","volume":"58","author":"D Westermann","year":"2009","journal-title":"Diabetes"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3892\/ijmm.2013.1368","article-title":"Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis","volume":"32","author":"PM Becher","year":"2013","journal-title":"International journal of molecular medicine"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.111.183913","article-title":"Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and beta-receptor blockade","volume":"59","author":"PM Becher","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00395-012-0308-y","article-title":"Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo","volume":"107","author":"D Westermann","year":"2012","journal-title":"Basic research in cardiology"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1074\/mcp.O111.014704","article-title":"PaxDb, a database of protein abundance averages across all three domains of life","volume":"11","author":"M Wang","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"7502","key":"ref32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature13302","article-title":"A draft map of the human proteome","volume":"509","author":"MS Kim","year":"2014","journal-title":"Nature"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/db08-0564","article-title":"High glucose induces toll-like receptor expression in human monocytes: mechanism of activation","volume":"57","author":"MR Dasu","year":"2008","journal-title":"Diabetes"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.5551\/jat.27292","article-title":"Angiotensin Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4","volume":"22","author":"S Matsuda","year":"2015","journal-title":"Journal of atherosclerosis and thrombosis"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: all we need to know about danger","volume":"81","author":"ME Bianchi","year":"2007","journal-title":"Journal of leukocyte biology"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"T Kawai","year":"2010","journal-title":"Nature immunology"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/HYPERTENSIONAHA.111.00614","article-title":"Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy","volume":"61","author":"DS Jiang","year":"2013","journal-title":"Hypertension"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCULATIONAHA.105.584532","article-title":"Myocarditis: current trends in diagnosis and treatment","volume":"113","author":"JW Magnani","year":"2006","journal-title":"Circulation"},{"issue":"23","key":"ref39","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1161\/01.CIR.0000136824.73458.20","article-title":"Protective role for interferon-beta in coxsackievirus B3 infection","volume":"110","author":"R Deonarain","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/74689","article-title":"The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease","volume":"6","author":"P Liu","year":"2000","journal-title":"Nature medicine"},{"issue":"Suppl 1","key":"ref41","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.thromres.2014.03.011","article-title":"Roles of PAR1 and PAR2 in viral myocarditis","volume":"133","author":"N Mackman","year":"2014","journal-title":"Thrombosis research"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ahj.2007.05.010","article-title":"Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy","volume":"154","author":"M Satoh","year":"2007","journal-title":"American heart journal"},{"issue":"6857","key":"ref43","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"L Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"21","key":"ref44","doi-asserted-by":"crossref","first-page":"12191","DOI":"10.1073\/pnas.95.21.12191","article-title":"Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-beta enhanceosome in vitro","volume":"95","author":"TK Kim","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/MCB.18.5.2986","article-title":"Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation","volume":"18","author":"R Lin","year":"1998","journal-title":"Molecular and cellular biology"},{"issue":"22","key":"ref46","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1093\/emboj\/17.22.6660","article-title":"Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7","volume":"17","author":"I Marie","year":"1998","journal-title":"The EMBO journal"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCGENETICS.114.000505","article-title":"Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis","volume":"7","author":"S Omura","year":"2014","journal-title":"Circulation Cardiovascular genetics"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbadis.2014.04.030","article-title":"Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease","volume":"1852","author":"GN Zhao","year":"2015","journal-title":"Biochimica et biophysica acta"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00995.2008","article-title":"Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart","volume":"296","author":"W Chao","year":"2009","journal-title":"American journal of physiology Heart and circulatory physiology"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/157340309788970405","article-title":"Toll-like receptors and myocardial ischemia\/reperfusion, inflammation, and injury","volume":"5","author":"DJ Kaczorowski","year":"2009","journal-title":"Current cardiology reviews"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2017.07.031","article-title":"Platelet Toll-like receptor (TLR) expression and TLR-mediated platelet activation in acute myocardial infarction","volume":"158","author":"KE Hally","year":"2017","journal-title":"Thromb Res"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.18295\/2075-0528.1648","article-title":"The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I\u2014Promoting inflammation and immunity","volume":"15","author":"WG Land","year":"2015","journal-title":"Sultan Qaboos University medical journal"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"828354","DOI":"10.1155\/2013\/828354","article-title":"S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease","volume":"2013","author":"A Schiopu","year":"2013","journal-title":"Mediators of inflammation"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbadis.2013.10.006","article-title":"Toll-like receptor 3 plays a role in myocardial infarction and ischemia\/reperfusion injury","volume":"1842","author":"C Lu","year":"2014","journal-title":"Biochimica et biophysica acta"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00395-012-0326-9","article-title":"Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy","volume":"108","author":"J Lu","year":"2013","journal-title":"Basic research in cardiology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"847827","DOI":"10.1155\/2014\/847827","article-title":"Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation","volume":"2014","author":"J Fuentes-Antras","year":"2014","journal-title":"International journal of endocrinology"},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"H Shi","year":"2006","journal-title":"The Journal of clinical investigation"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MOL.0b013e32832fa5c4","article-title":"Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome","volume":"20","author":"MB Fessler","year":"2009","journal-title":"Current opinion in lipidology"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc09-1799","article-title":"Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects","volume":"33","author":"MR Dasu","year":"2010","journal-title":"Diabetes care"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1152\/ajpendo.00302.2006","article-title":"Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes","volume":"292","author":"SJ Creely","year":"2007","journal-title":"American journal of physiology Endocrinology and metabolism"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/MED.0b013e3283073a46","article-title":"Innate immunity and its role in type 1 diabetes","volume":"15","author":"D Zipris","year":"2008","journal-title":"Current opinion in endocrinology, diabetes, and obesity"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/156652409787314453","article-title":"The role of Toll-like receptor pathways in the mechanism of type 1 diabetes","volume":"9","author":"E Lien","year":"2009","journal-title":"Current molecular medicine"},{"issue":"8","key":"ref63","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/dmrr.1256","article-title":"Innate immunity in type 1 diabetes","volume":"27","author":"D Zipris","year":"2011","journal-title":"Diabetes\/metabolism research and reviews"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"E485","DOI":"10.1152\/ajpendo.00505.2012","article-title":"Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance","volume":"305","author":"XA Wang","year":"2013","journal-title":"American journal of physiology Endocrinology and metabolism"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2741\/3923","article-title":"Angiotensin II induces inflammation leading to cardiac remodeling","volume":"17","author":"L Jia","year":"2012","journal-title":"Frontiers in bioscience"},{"issue":"3","key":"ref66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3317\/jraas.2003.030","article-title":"Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice","volume":"4","author":"CE Huggins","year":"2003","journal-title":"Journal of the renin-angiotensin-aldosterone system: JRAAS"},{"issue":"4\u20136","key":"ref67","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000218173","article-title":"Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells","volume":"23","author":"Y Ji","year":"2009","journal-title":"Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T20:08:16Z","timestamp":1751486896000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193844"}},"subtitle":[],"editor":[{"given":"Dong-Yan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193844","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]}}}